Bionano Genomics Stock Forward View - Accumulation Distribution
| BNGO Stock | USD 1.10 0.01 0.92% |
Bionano Stock outlook is based on your current time horizon. Although Bionano Genomics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Bionano Genomics' systematic risk associated with finding meaningful patterns of Bionano Genomics fundamentals over time.
As of today the relative strength index (rsi) of Bionano Genomics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (2.14) | EPS Estimate Current Year (7.72) | EPS Estimate Next Year (2.49) | Wall Street Target Price 7.5 | EPS Estimate Current Quarter (2.34) |
Using Bionano Genomics hype-based prediction, you can estimate the value of Bionano Genomics from the perspective of Bionano Genomics response to recently generated media hype and the effects of current headlines on its competitors.
Bionano Genomics after-hype prediction price | USD 1.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections. Bionano Genomics Additional Predictive Modules
Most predictive techniques to examine Bionano price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionano using various technical indicators. When you analyze Bionano charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 4897.21 | 0.0526 |
| Check Bionano Genomics Volatility | Backtest Bionano Genomics | Information Ratio |
Bionano Genomics Trading Date Momentum
| On February 15 2026 Bionano Genomics was traded for 1.10 at the closing time. The top price for the day was 1.14 and the lowest listed price was 1.08 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Bionano Genomics to competition |
Other Forecasting Options for Bionano Genomics
For every potential investor in Bionano, whether a beginner or expert, Bionano Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bionano Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bionano. Basic forecasting techniques help filter out the noise by identifying Bionano Genomics' price trends.Bionano Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionano Genomics stock to make a market-neutral strategy. Peer analysis of Bionano Genomics could also be used in its relative valuation, which is a method of valuing Bionano Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bionano Genomics Market Strength Events
Market strength indicators help investors to evaluate how Bionano Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionano Genomics shares will generate the highest return on investment. By undertsting and applying Bionano Genomics stock market strength indicators, traders can identify Bionano Genomics entry and exit signals to maximize returns.
Bionano Genomics Risk Indicators
The analysis of Bionano Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bionano Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bionano stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.61 | |||
| Standard Deviation | 3.56 | |||
| Variance | 12.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bionano Genomics
The number of cover stories for Bionano Genomics depends on current market conditions and Bionano Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionano Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionano Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bionano Genomics Short Properties
Bionano Genomics' future price predictability will typically decrease when Bionano Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bionano Genomics often depends not only on the future outlook of the potential Bionano Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bionano Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 9.5 M |
Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Life Sciences Tools & Services sector continue expanding? Could Bionano diversify its offerings? Factors like these will boost the valuation of Bionano Genomics. Projected growth potential of Bionano fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bionano Genomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.77) | Revenue Per Share | Quarterly Revenue Growth 0.213 | Return On Assets | Return On Equity |
Investors evaluate Bionano Genomics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Bionano Genomics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Bionano Genomics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Bionano Genomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bionano Genomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Bionano Genomics' market price signifies the transaction level at which participants voluntarily complete trades.